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Alzheimer’s Protein Jams Mitochondria of Affected Cells
by Stephen Bradt

Opening a new front in the battle against
Alzheimer’s disease, scientists at the School
have found that a protein long associated with
the disease inflicts grave damage in a previously unimagined way: It seals off mitochondria
in affected neurons, resulting in an “energy
crisis” and buildup of toxins that causes cells
to die. This pathway, the first specific biochemical explanation for pathologies associated with Alzheimer’s, was detailed in the April
14 issue of the Journal of Cell Biology.
While the normal function of the amyloid
precursor protein (APP) remains unknown,
senior author Dr. Narayan G. Avadhani and
his colleagues have determined that a mere 50amino-acid stretch of the protein wreaks
havoc by essentially starving mitochondria
and the cells they nourish.
“We found that when APP leaves the nucleus, it can be directed both to mitochondria
and to the endoplasmic reticulum,” said
Avadhani, Harriet Ellison Woodward Professor
of Biochemistry and chair of the Department
of Animal Biology in the School. “APP has an
acidic, negatively charged region that causes it
to jam irreversibly while traversing protein
transport channels in the mitochondrial membrane. This hampers, and eventually completely blocks, mitochondria’s ability to import
other proteins and produce cellular energy.”
As if suffocating the cell’s power plant
weren’t enough, jammed APP proteins also
damaged the mouse neurons studied by
Avadhani and co-author Dr. Hindupur K.
Anandatheerthavarada in a second way. The
end of the protein left dangling outside the
mitochondrion contains a toxic product called
A-Beta. The researchers found that this toxin,
a known component of the brain plaques and
tangles that are a hallmark of Alzheimer’s, is
cleaved from the rest of the immobilized protein and accumulates in the cell.
“Researchers have observed many
biochemical and biophysical phenomena
associated with Alzheimer’s disease,” said
Anandatheerthavarada, research assistant
professor of biochemistry and the paper’s first
author, “but it has remained unclear whether
these are causes of Alzheimer’s or merely side
effects. The pathway we observed, which leads
directly to common symptoms, is the first
with a demonstrated ability to cause the
neuronal death associated with Alzheimer’s
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disease.”
The results are consistent with the progressive nature of Alzheimer’s and other neurodegenerative diseases, the scientists said. As pores
in the mitochondrial membrane clog with proteins – inaccessible to enzymes that might normally degrade them – cellular function is
steadily and inevitably reduced until cell death,

Mitochondria showing the translocation-arrested APP
proteins. Circular images show confocal immunofluorescent images of mitochondria.

reached when APP succeeds in suffocating all
the cell’s mitochondria.
Avadhani and Anandatheerthavarada’s
results put a dent in cell biology dogma, which

holds that each of the proteins produced in the
nucleus can be directed to only one location in
the cell. In APP’s case, the Penn scientists have
shown the targeting sequence within the protein’s N-terminal directs it to at least two locations, the mitochondrion and endoplasmic
reticulum.
The implication of mitochondrial failure is
unexpected because most Alzheimer’s
researchers, believing the mitochondrion was
not on APP’s itinerary, have focused on the
protein’s effects on other organelles. In fact,
Avadhani and Anandatheerthavarada found
that mitochondria appear to be the only
organelles whose membranes have trouble handling APP.
It remains unclear whether APP gets stuck
in mitochondria’s protein entryways because of
its negative charge or bulkiness attributable to
improper protein folding. Avadhani and Anandatheerthavarada plan to study the question,
which could eventually yield medications to
correct the problem.
“A mutant version of APP without the
region that’s prone to jamming passes into the
mitochondria without a hitch,” Avadhani said.
“This suggests that pharmaceuticals could be
developed to fix this domain, either by neutralizing its charge or folding it more tightly.”
Avadhani and Anandatheerthavarada were
joined in this research by Dr. Gopa Biswas and
Mary-Anne Robin, both of the School’s
Department of Animal Biology. Their work was
funded by the National Institutes of Health.

Construction of State-of-the-art
Operating Room at New Bolton Center
New Bolton Center’s unique orthopedic
surgical facility with its pool recovery system
is undergoing a $2 million renovation and
expansion. A new, state-of-the-art operating
room for large animals will be constructed
in the C. Mahlon Kline Orthopedic and
Rehabilitation Center adjacent to the current operating room. That will be refurbished and will be used for minor surgeries
and bandage changes. An additional recovery stall will be built adjacent to the recovery
pool used for horses emerging from anes-

thesia. The pool will be altered slightly by
the removal of the ramp.
While the Kline Center renovations are
under way, equine orthopedic surgeries will
be handled in an operating suite in another
building. Patients will be recovered from
anesthesia in a stall.
It is anticipated that the renovation and
expansion of the orthopedic surgical facilities will be completed by the end of the
summer of 2003.

